![]() |
Name |
1-Iodooctadecane
|
Molecular Formula | C18H37I | |
IUPAC Name* |
1-iodooctadecane
|
|
SMILES |
CCCCCCCCCCCCCCCCCCI
|
|
InChI |
InChI=1S/C18H37I/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h2-18H2,1H3
|
|
InChIKey |
ZNJOCVLVYVOUGB-UHFFFAOYSA-N
|
|
Synonyms |
1-IODOOCTADECANE; Octadecyl iodide; 629-93-6; Stearyl iodide; Octadecane, 1-iodo-; n-Octadecyl iodide; K8J7D7A7XG; NSC-5544; iodooctadecane; octadecyliodide; Octadecyljodid; NSC 5544; EINECS 211-117-3; 1-Iodooctadecane, 95%; UNII-K8J7D7A7XG; SCHEMBL226201; DTXSID7060881; NSC5544; ZINC6920368; MFCD00001090; AKOS015839785; AS-56768; CS-0179367; FT-0607967; I0065; D91071; W-104944
|
|
CAS | 629-93-6 | |
PubChem CID | 12402 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 380.4 | ALogp: | 10.7 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 16 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 19 | QED Weighted: | 0.143 |
Caco-2 Permeability: | -4.934 | MDCK Permeability: | 0.00000728 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.138 |
30% Bioavailability (F30%): | 0.993 |
Blood-Brain-Barrier Penetration (BBB): | 0.032 | Plasma Protein Binding (PPB): | 98.84% |
Volume Distribution (VD): | 3.696 | Fu: | 1.17% |
CYP1A2-inhibitor: | 0.147 | CYP1A2-substrate: | 0.18 |
CYP2C19-inhibitor: | 0.3 | CYP2C19-substrate: | 0.059 |
CYP2C9-inhibitor: | 0.065 | CYP2C9-substrate: | 0.949 |
CYP2D6-inhibitor: | 0.237 | CYP2D6-substrate: | 0.069 |
CYP3A4-inhibitor: | 0.18 | CYP3A4-substrate: | 0.039 |
Clearance (CL): | 4.081 | Half-life (T1/2): | 0.04 |
hERG Blockers: | 0.257 | Human Hepatotoxicity (H-HT): | 0.039 |
Drug-inuced Liver Injury (DILI): | 0.609 | AMES Toxicity: | 0.028 |
Rat Oral Acute Toxicity: | 0.063 | Maximum Recommended Daily Dose: | 0.032 |
Skin Sensitization: | 0.955 | Carcinogencity: | 0.054 |
Eye Corrosion: | 0.996 | Eye Irritation: | 0.952 |
Respiratory Toxicity: | 0.863 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000380 | ![]() |
0.891 | D00AOJ | ![]() |
0.694 | ||
ENC000527 | ![]() |
0.833 | D07ILQ | ![]() |
0.597 | ||
ENC000428 | ![]() |
0.833 | D00FGR | ![]() |
0.548 | ||
ENC000521 | ![]() |
0.833 | D0Z5SM | ![]() |
0.535 | ||
ENC000284 | ![]() |
0.833 | D05ATI | ![]() |
0.457 | ||
ENC000745 | ![]() |
0.794 | D0O1PH | ![]() |
0.440 | ||
ENC000285 | ![]() |
0.794 | D00STJ | ![]() |
0.420 | ||
ENC000486 | ![]() |
0.783 | D0T9TJ | ![]() |
0.354 | ||
ENC000400 | ![]() |
0.783 | D0P1RL | ![]() |
0.340 | ||
ENC001124 | ![]() |
0.769 | D00MLW | ![]() |
0.324 |